In conclusion, IL-33 has no ST2-dependent effects on human lung fibroblasts in vitro nor does it act as a major fibrotic mediator in either the BLM mouse model of pulmonary fibrosis or human PCLS. Here, IL33 is linked to pulmonary fibrosis.